Todd Ringler

How Arizona has kept its iced tea 99 cents. (Source: Arizona Beverages, 2025)

Gen Z is drinking 20% less than Millennials. Productivity is rising. Coincidence? Not quite fortune.com/2025/12/13/gen…

TE Connectivity’s annual survey of engineers and executives revealed many are pessimistic about their companies’ commitment to sustainability. emergingtechbrew.com/stories/2025/0… via @MorningBrew

TE Connectivity survey show inconsistent use of AI globally prn.to/3D4Hm6U In China, 28% of company respondents are using AI extensively & 60% have been using for at least 3 yrs. In US 15% say their company is using AI extensively & only 9% report using in same timeframe

At War, Because We’re at Work cjr.org/the_media_toda… via @cjr

Early detection of #NCDs through screening can identify risk factors and early signs, enabling timely intervention and management. This not only improves patient outcomes but also reduces healthcare costs and the socio-economic impact of these diseases ~ @DestaLakew #AmrefAtWHA77 #WHA77

Merck KGaA to buy gene therapy tools maker for $600M biopharmadive.com/news/millipore… $MKKGY by Kristin Jensen

The #climate crisis has led to severe flooding in Kenya, resulting in over 300 deaths and leaving more than 1000 pregnant women at risk of displacement. #Amref is collaborating with partners around the clock to administer cholera vaccinations to the affected communities. - @daktari1 #WHA77 #AmrefAtWHA77 #OneHealth @AfricaCDC @MoetiTshidi @JeanKaseya2 @WHOAFRO @WHO @DestaLakew

Dr. Githinji Gitahi from @Amref_Worldwide speaking at #WorldHealthAssembly presser "...we cannot afford to throw money at the health problem [in Africa] but we can afford to throw our knowledge at health" #amrefAtWHA77 #WHA77

Therapies designed to dismantle cancer’s escape mechanisms show promise for patients biopharmadive.com/spons/therapie… via @BioPharmaDive

Tech industry struggling to align aspirations with sustainability planning edie.net/tech-industry-…

The price of AI is tricky to determine fortune.com/2024/05/02/the…

How mRNA vaccines could be personalized cancer cures axios.com/2024/05/07/how… Broad-based treatments have the advantage of getting patients to treatment quicker than personalized vaccines, said Mai-Britt Zocca, CEO @IOBiotech, which has a melanoma vaccine in phase 3 trial.

More trust themselves to manage their health as they shun institutions axios.com/2024/04/18/pub…

What about the over-under on "the forgotten valve"? I counted two, but may be wrong here, too. I always liked the phrase, but @ShelleyWood2 says I can never use it again in a story (it's forgotten no more!).

Dana-Farber researchers moving to retract paper in broad investigation statnews.com/2024/01/19/dan…

@MikeHuckman @shwen Clearly i don't know where the camera lens is! LOL! Great seeing you both!

I love this @shwen selfie with @ToddRingler #JPM24 (In front of the Victoria’s Secret next to the Westin.)

It’s that time again….#JPM2024. Hoping the NYC weather gods will be kind. 🙏🙇‍♂️🙏. See you all at the show.

Sanofi says it has 12 blockbusters in its back pocket. Will investors believe it? statnews.com/2023/12/06/san… via @statnews

My sister in law Hagar, my niece Ofri and my two nephews Yuval and Uriah were kidnapped into Gaza. We want them home where they belong. #BringThemHowNow